drugset / Trial / NCT02269176
Efficacy and Safety of Telmisartan and Losartan in Primary Hypertension
RandomizedParallel-groupDouble-blindTreatment
Summary
Using Losartan as a comparator, to evaluate the efficacy and safety of telmisartan in the treatment of the mild to moderate primary hypertension patients in China
Timeline
- Start
- 2000-07
- Primary completion
- 2001-01
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Losartan | Other / unclassified | 50 mg | — |
| Comparator | Losartan | Other / unclassified | 100 mg | — |
| Subject | Telmisartan | Other / unclassified | 40 mg | — |
| Subject | Telmisartan | Other / unclassified | 80 mg | — |